Biozatix News – Informasi Popular Sains, Teknologi dan Kesehatan Animal IHC detection and antibody Use PromARK™ reagents to virtually eliminate endogenous rodent IgG background staining, boost signal, and substantially enhance antibody titers on mouse and rat tissues. This is especially
Biozatix News – Informasi Popular Sains, Teknologi dan Kesehatan SOX10 Mouse Monoclonal Antibody SOX10 (M) [BC34] from Biocare Medical is an exclusive IVD mouse monoclonal antibody that provides a highly specific and sensitive antibody for immunohistochemistry and is virtually background
Biozatix News – Informasi Popular Sains, Teknologi dan Kesehatan Antibody Rabbit Monoclonal Biocare Medical is pleased to highlight our current menu of rabbit monoclonal antibodies as a complement to our existing line of exceptional IHC reagents. Studies have shown that, due to
Biozatix News – Informasi Popular Sains, Teknologi dan Kesehatan Antibody Prostate Cancer Focused IHC Prostate cancer remains the leading cancer among men in the United States with 238,590 newly diagnosed cases and 29,720 deaths in 2012. The number of new cases
Biozatix News – Informasi Popular Sains, Teknologi dan Kesehatan Antibody Mouse monoclonal anti-p40 [BC28] demonstrated similar sensitivity and specificity as the rabbit polyclonal p40, staining 97% (65/67) of cases of lung squamous cell carcinoma (SqCC) and 0% (0/71) cases of lung adenocarcinoma
Biozatix News – Informasi Popular Sains, Teknologi dan Kesehatan Mortality rates from breast cancer have steadily decreased in women since 1989 which has been attributed to progress made in early detection and improved treatment. The discovery and application of new
Biozatix News – Informasi popular Sains Teknologi dan Kedokteran Panel Carcinoma dengan positive (+) antibody Panel Carcinoma Panel Positive (+) Markers Squamous Cell Carcinoma Desmoglein-3 / CK5 / p40 / p63 Adenocarcinoma LMW CK (CK8/18) / CK7 / CK19 Lung,
Biozatix News – Informasi Popular Sains Teknologi dan Kedokteran Untuk menegakkan diagnosis pada beberapa jenis kanker, maka para ahli telah membuat guide line yang diterima secara umum untuk beberapa jenis kanker. namun demikian panel-panel ini terus mengalami perubahan dan perkembangan
